These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8164373)

  • 1. [Synthetic glucocorticoid therapy in liver diseases].
    Iino S; Hino K; Yasuda K
    Nihon Rinsho; 1994 Mar; 52(3):719-27. PubMed ID: 8164373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis.
    Trouillot TE; Shrestha R; Kam I; Wachs M; Everson GT
    Liver Transpl Surg; 1999 Sep; 5(5):375-80. PubMed ID: 10477838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis with unusual initial presentation as fulminant hepatic failure.
    Kayacetin E; Köklü S; Temuçin T
    Dig Liver Dis; 2004 Jun; 36(6):419-22. PubMed ID: 15248383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
    Pedrosa MC; Rohrer RM; Kaplan MM
    Clin Transplant; 1995 Aug; 9(4):322-5. PubMed ID: 7579741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of autoimmune hepatic diseases].
    Bueverov AO
    Klin Med (Mosk); 2004; 82(10):62-6. PubMed ID: 15584604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis.
    Ozaslan E; Efe C; Akbulut S; Purnak T; Savas B; Erden E; Altiparmak E
    Hepatogastroenterology; 2010; 57(99-100):441-6. PubMed ID: 20698205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients.
    Thiele DL; DuCharme L; Cunningham MR; Mimms LT; Cuthbert JA; Lee WM; Combes B
    Am J Gastroenterol; 1996 Feb; 91(2):300-8. PubMed ID: 8607497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive therapy in chronic liver disease.
    Sherlock S
    Minerva Med; 1978 Aug; 69(38):2605-9. PubMed ID: 714260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical features of 107 autoimmune hepatitis patients and 30 of them with AIH-primary biliary cirrhosis overlap syndrome].
    Qiu DK; Li XM; Wei J; Ye LJ; Peng YS; Ma X
    Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):367-71. PubMed ID: 18510851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell subsets in autoimmune and HBV-induced chronic liver disease, HBs antigen carriers with normal histology and primary biliary cirrhosis: a review of the abnormalities and the effects of treatment.
    Thomas HC; Brown D; Labrooy J; Epstein O
    J Clin Immunol; 1982 Jul; 2(3 Suppl):57S-60S. PubMed ID: 6752180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azathioprine for long-term maintenance of remission in autoimmune hepatitis.
    Johnson PJ; McFarlane IG; Williams R
    N Engl J Med; 1995 Oct; 333(15):958-63. PubMed ID: 7666914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A in nontransplant-related liver disease.
    Minuk GY
    Am J Gastroenterol; 1989 Nov; 84(11):1345-50. PubMed ID: 2683736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glucocorticoids and immunosuppressive agents in liver diseases].
    Arpa Gutierrez FJ; Silva Pozo J
    Rev Esp Enferm Apar Dig; 1970 Dec; 32(7):763-82. PubMed ID: 4926636
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the problem of effects and side effects of steroids and liver hydrolysates in acute and chronic liver diseases].
    Kleine FD
    Z Arztl Fortbild (Jena); 1966 Aug; 60(15):900-4. PubMed ID: 5995281
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification and characterization of IgG4-associated autoimmune hepatitis.
    Chung H; Watanabe T; Kudo M; Maenishi O; Wakatsuki Y; Chiba T
    Liver Int; 2010 Feb; 30(2):222-31. PubMed ID: 19650840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic liver diseases: current therapeutic options.
    Kaplan MM
    Hosp Pract (Off Ed); 1989 Mar; 24(3):111-6, 121-3, 126-30. PubMed ID: 2493463
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis.
    Ben-Ari Z; Dhillon AP; Sherlock S
    Hepatology; 1993 Jul; 18(1):10-5. PubMed ID: 8100797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PBC-AIH overlap syndrome with concomitant ITP and Hashimoto's disease with positivity for anti-centromere antibody.
    Arakawa Y; Amaki S; Miyakawa H; Sakai T; Gotou I; Tanaka N; Moriyama M; Iwasaki A; Sugitani M; Arakawa Y
    J Gastroenterol; 2004; 39(5):490-5. PubMed ID: 15175950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.